Home » Methodist Hospital joins UK Markey Cancer Center Affiliate Network

Methodist Hospital joins UK Markey Cancer Center Affiliate Network

Henderson hospital is a 192-bed acute care facility

LEXINGTON, Ky. (Sept. 19, 2014) — Methodist Hospital in Henderson and the University of Kentucky Markey Cancer Center, the state’s first and only National Cancer Institute-designated cancer center, are joining forces, announcing today that the two organizations have joined into an affiliation.

Methodist Hospital.
Methodist Hospital.

“The Methodist Hospital affiliation with the UK Markey Cancer Center brings to this region nationally ranked cancer treatment close to home,” said Bruce Begley CEO of Methodist Hospital.  We believe this is a big step in the continuing battle against cancer, and I appreciate UK HealthCare’s overall mission of extending high-quality cancer care to all Kentuckians.”

The UK Markey Cancer Center Affiliate Network was created to provide high-quality cancer care closer to home for patients across the region, and to minimize the effects of cancer through prevention and education programs, exceptional clinical care, and access to research.

Methodist Hospital in Henderson is a 192-bed acute care facility and is just one facet of the Methodist Hospital Healthcare system. Other facilities serving the area include Methodist Hospital Union County, a critical access hospital in nearby Morganfield and 19 outpatient physician offices with 47 providers over a four-county service area.

The Methodist Hospital Healthcare system will now be able to offer their patients access to additional specialty and subspecialty physicians and care, including clinical trials and advanced technology, while allowing them to stay in western Kentucky for most treatments.

“We are extremely excited and proud for our cancer care program to become an affiliate of the Markey Cancer Center,” said Dr. Arshad Husain, medical director of hematology and oncology at Methodist Hospital. “This alliance means great things for our patients. It will enable us to offer access to the latest practices in diagnosis and treatment of cancers and blood disorders, including clinical trials – thus providing a higher level of cancer care in our neighborhood.”